OSLER DELPHI
LIVE

Serial Number

79253505

Owner

Osler Diagnostics Limited

Attorney

Eric Lamb

Filing Date

Jan 29, 2019

Add to watchlist:

No watchlists yet
View on USPTO

OSLER DELPHI Trademark

Serial Number: 79253505 • Registration: 6177054

OSLER DELPHI is a trademark filed by Osler Diagnostics Limited on January 29, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Osler Diagnostics Limited (12 trademarks)

King Charles House,

Entity Type: 99

Trademark Details

Filing Date

January 29, 2019

Registration Date

October 20, 2020

Published for Opposition

March 3, 2020

Goods & Services

Medical services; medical testing for diagnostic purposes; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Assays and reagents for scientific or medical research purposes

Scientific apparatus and instruments, namely, hand-held devices for withdrawing and testing blood for clinical, research, and scientific purposes and parts and fittings therefor; material testing apparatus and instruments, namely, electronic apparatus for identifying and testing pathogens and biomarkers in blood for clinical, research, and scientific purposes; monitoring, measuring, signaling and control apparatus and instruments, namely, apparatus and instruments for testing blood against a panel of biomarkers for clinical, research, and scientific purposes; audiovisual receivers; computer apparatus and instruments, namely, computer hardware and computer peripheral apparatus; recorded computer software for analyzing data obtained from blood samples; downloadable computer software for analyzing data obtained from blood samples; recorded application software for analyzing data obtained from blood samples; computer hardware for data capture, collection, recording, processing, transmission, reproduction, storage and communications; electrical and electronic components for computers; parts and fittings for all the aforementioned goods *, none of the aforementioned services being related to, connected with or for use in or relating to vehicles, including but not limited to automotive, aircraft, watercraft, vehicle parts, vehicle accessories, vehicle component systems or the automotive industry, or being related to or connected with the fields of transportation and mobility *

Intellectual property licensing services; licensing of technology; licensing of manufacturing technology and/or manufacturing processes; licensing of intellectual property and/or intellectual property rights; licensing of industrial property and/or industrial property rights; licensing of patents and intellectual property in the field of confidential information, technical information and/or know-how; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Medical apparatus and instruments for use in obtaining blood samples; medical apparatus and instruments for testing blood for diagnostic use; medical apparatus and instruments for identifying pathogens and biomarkers from blood samples; diagnostic testing apparatus and instruments for the measurement of clinical biomarkers; parts and fittings for all the aforementioned goods

Product research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; new product design services; research, design and development of medical apparatus and instruments; research, design and development of medical diagnostic apparatus and instruments; research, design and development of diagnostic tests for the measurement of clinical biomarkers; consultancy, advisory and/or information services relating to or connected with the aforementioned services *, none of the aforementioned services being related to, connected with or for use in or relating to vehicles, including but not limited to automotive, aircraft, watercraft, vehicle parts, vehicle accessories, vehicle component systems or the automotive industry, or being related to or connected with the fields of transportation and mobility *

Research in the field of education; consultancy, advisory and/or information services relating to or connected with the aforementioned services *, none of the aforementioned services being related to, connected with or for use in or relating to vehicles, including but not limited to automotive, aircraft, watercraft, vehicle parts, vehicle accessories, vehicle component systems or the automotive industry, or being related to or connected with the fields of transportation and mobility *

Pharmaceuticals for treating viruses, infections, infectious diseases, and skin disorders; medical preparations for treating viruses, infections, infectious diseases, and skin disorders; chemical preparations and reagents for medical purposes for treating viruses, infections, infectious diseases, and skin disorders; diagnostic preparations, substances, agents, reagents, assays and materials for medical purposes; diagnostic testing preparations, substances, agents, reagents, assays and materials for medical purposes, namely, for testing blood and body fluids

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 20, 2025 REM3
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 8, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 8, 2023 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 2, 2023 NREP
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Jul 3, 2023 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 4, 2023 INPR
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
May 11, 2023 LIMN
LIMITATION OF GOODS RECEIVED FROM IB
Mar 4, 2023 LIMG
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 28, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 28, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 28, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 28, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 28, 2023 COAR
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Nov 8, 2022 NURC
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 7, 2022 LIMN
AMENDMENT UNDER SECTION 7 - PROCESSED
Oct 4, 2022 A7OK
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 29, 2022 APRE
LIMITATION OF GOODS RECEIVED FROM IB
Jun 5, 2022 LIMG
TEAS SECTION 7 REQUEST RECEIVED
Apr 25, 2022 ES7R
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 20, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 2, 2021 FICS
FINAL DISPOSITION PROCESSED
Feb 2, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 20, 2020 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Sep 10, 2020 ETOP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 29, 2020 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 12, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 12, 2020 OPNR
EXTENSION OF TIME TO OPPOSE RECEIVED
Mar 30, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 3, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 3, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Feb 28, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 12, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 27, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 22, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 22, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 22, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 22, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 24, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2019 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jul 26, 2019 NREP
REFUSAL PROCESSED BY IB
Jul 12, 2019 RFNT
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 5, 2019 ADCH
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 25, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 24, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jun 10, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Jun 7, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 19, 2019 RFCR
NON-FINAL ACTION WRITTEN
May 18, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
May 3, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 18, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 17, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 10, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 15, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 11, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2019 REPR